Low-Dose (15 mg/day) Pioglitazone Treatment Improves Glycemic Control, and Whole-Body and Adipocyte Insulin Resistance With Minimal Weight Gain in Type 2 Diabetic Subjects

DIABETES(2012)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要